• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于微藻生物质的肠道疾病口服治疗策略。

Orally deliverable strategy based on microalgal biomass for intestinal disease treatment.

作者信息

Zhong Danni, Zhang Dongxiao, Chen Wei, He Jian, Ren Chaojie, Zhang Xingcai, Kong Na, Tao Wei, Zhou Min

机构信息

Eye Center, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Institute of Translational Medicine, Zhejiang University, Hangzhou, China.

出版信息

Sci Adv. 2021 Nov 26;7(48):eabi9265. doi: 10.1126/sciadv.abi9265. Epub 2021 Nov 24.

DOI:10.1126/sciadv.abi9265
PMID:34818040
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8612690/
Abstract

Design of innovative strategies for oral drug delivery is particularly promising for intestinal disease treatment. However, many obstacles such as poor therapeutic efficacy and low bioavailability and biocompatibility remain to be addressed. Here, we report a versatile formulation based on a helical-shaped cyanobacterium, (SP), loaded with curcumin (SP@Curcumin) for the treatment of colon cancer and colitis, two types of intestinal diseases. In radiotherapy for colon cancer, SP@Curcumin could mediate combined chemo- and radiotherapy to inhibit tumor progression while acting as a radioprotector to scavenge reactive oxygen species induced by the high dose of x-ray radiation in healthy tissues. SP@Curcumin could also reduce the production of proinflammatory cytokines and thereby exerted anti-inflammatory effects against colitis. The oral drug delivery system not only leveraged the biological properties of microalgal carriers to improve the bioavailability of loaded drugs but also performed excellent antitumor and anti-inflammation efficacy for intestinal disease treatment.

摘要

设计用于口服给药的创新策略对于肠道疾病治疗特别有前景。然而,许多障碍,如治疗效果差、生物利用度低以及生物相容性问题仍有待解决。在此,我们报告了一种基于螺旋形蓝藻(SP)负载姜黄素(SP@姜黄素)的多功能制剂,用于治疗两种肠道疾病——结肠癌和结肠炎。在结肠癌的放射治疗中,SP@姜黄素可以介导化疗和放疗联合作用以抑制肿瘤进展,同时作为辐射防护剂清除健康组织中高剂量X射线辐射诱导产生的活性氧。SP@姜黄素还可以减少促炎细胞因子的产生,从而对结肠炎发挥抗炎作用。该口服给药系统不仅利用了微藻载体的生物学特性来提高负载药物的生物利用度,而且在肠道疾病治疗中表现出优异的抗肿瘤和抗炎功效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaab/8612690/9b5bcbd1e478/sciadv.abi9265-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaab/8612690/421f680e7692/sciadv.abi9265-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaab/8612690/482fece60e0c/sciadv.abi9265-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaab/8612690/65b85e0c8559/sciadv.abi9265-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaab/8612690/660b1441c130/sciadv.abi9265-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaab/8612690/f2c3fe81f98f/sciadv.abi9265-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaab/8612690/d10126433836/sciadv.abi9265-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaab/8612690/9b5bcbd1e478/sciadv.abi9265-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaab/8612690/421f680e7692/sciadv.abi9265-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaab/8612690/482fece60e0c/sciadv.abi9265-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaab/8612690/65b85e0c8559/sciadv.abi9265-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaab/8612690/660b1441c130/sciadv.abi9265-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaab/8612690/f2c3fe81f98f/sciadv.abi9265-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaab/8612690/d10126433836/sciadv.abi9265-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaab/8612690/9b5bcbd1e478/sciadv.abi9265-f7.jpg

相似文献

1
Orally deliverable strategy based on microalgal biomass for intestinal disease treatment.基于微藻生物质的肠道疾病口服治疗策略。
Sci Adv. 2021 Nov 26;7(48):eabi9265. doi: 10.1126/sciadv.abi9265. Epub 2021 Nov 24.
2
Orally Deliverable Microalgal-Based Carrier with Selenium Nanozymes for Alleviation of Inflammatory Bowel Disease.用于缓解炎症性肠病的含硒纳米酶的口服微藻基载体
ACS Appl Mater Interfaces. 2024 Sep 25;16(38):50212-50228. doi: 10.1021/acsami.4c08020. Epub 2024 Sep 12.
3
aqueous extracts ameliorate colonic mucosal damage and modulate gut microbiota disorder in mice with ulcerative colitis by inhibiting inflammation and oxidative stress.水提物通过抑制炎症和氧化应激改善溃疡性结肠炎小鼠的结肠黏膜损伤和调节肠道微生物失调。
J Zhejiang Univ Sci B. 2022 Jun 15;23(6):481-501. doi: 10.1631/jzus.B2100988.
4
Novel formulation of solid lipid microparticles of curcumin for anti-angiogenic and anti-inflammatory activity for optimization of therapy of inflammatory bowel disease.姜黄素固体脂质微粒的新型制剂用于抗血管生成和抗炎活性以优化炎症性肠病的治疗
J Pharm Pharmacol. 2009 Mar;61(3):311-21. doi: 10.1211/jpp/61.03.0005.
5
Carboxymethyl chitosan microspheres loaded hyaluronic acid/gelatin hydrogels for controlled drug delivery and the treatment of inflammatory bowel disease.载透明质酸/明胶水凝胶的羧甲基壳聚糖微球用于控制药物释放和治疗炎症性肠病。
Int J Biol Macromol. 2021 Jan 15;167:1598-1612. doi: 10.1016/j.ijbiomac.2020.11.117. Epub 2020 Nov 18.
6
Colon targeted oral drug delivery system based on alginate-chitosan microspheres loaded with icariin in the treatment of ulcerative colitis.基于负载淫羊藿苷的海藻酸钠-壳聚糖微球的结肠靶向口服给药系统治疗溃疡性结肠炎
Int J Pharm. 2016 Dec 30;515(1-2):176-185. doi: 10.1016/j.ijpharm.2016.10.002. Epub 2016 Oct 3.
7
Anti-inflammatory effects of an oxylipin-containing lyophilised biomass from a microalga in a murine recurrent colitis model.一种微藻含氧化脂质冻干生物质在小鼠复发性结肠炎模型中的抗炎作用
Br J Nutr. 2016 Dec;116(12):2044-2052. doi: 10.1017/S0007114516004189. Epub 2016 Dec 27.
8
Biodegradable Microalgae-Based Carriers for Targeted Delivery and Imaging-Guided Therapy toward Lung Metastasis of Breast Cancer.基于可生物降解微藻的载体用于靶向递药和成像引导治疗乳腺癌肺转移
Small. 2020 May;16(20):e2000819. doi: 10.1002/smll.202000819. Epub 2020 Apr 15.
9
Oral Microalgae-Nano Integrated System against Radiation-Induced Injury.口腔藻类-纳米综合系统对抗辐射诱导损伤。
ACS Nano. 2023 Jun 13;17(11):10560-10576. doi: 10.1021/acsnano.3c01502. Epub 2023 May 30.
10
A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin.一种用于提高姜黄素口服生物利用度和抗癌疗效的络合与自纳米乳化药物递送系统组合。
Drug Dev Ind Pharm. 2017 May;43(5):847-861. doi: 10.1080/03639045.2016.1239732. Epub 2016 Oct 6.

引用本文的文献

1
Advancements of algae-involved cancer treatment.涉及藻类的癌症治疗进展。
Biophys Rep. 2025 Aug 31;11(4):258-282. doi: 10.52601/bpr.2024.240055.
2
Biomimetic magnetobacterial microrobots for active pneumonia therapy.用于活性肺炎治疗的仿生磁细菌微型机器人。
Nat Commun. 2025 Aug 22;16(1):7856. doi: 10.1038/s41467-025-63231-6.
3
Microalgae-based Intestinal villi-targeting multistage biosystem for irritable bowel syndrome treatment.基于微藻的靶向肠绒毛多级生物系统用于治疗肠易激综合征

本文引用的文献

1
Multifunctional biohybrid magnetite microrobots for imaging-guided therapy.多功能生物杂交磁铁微机器人用于成像引导治疗。
Sci Robot. 2017 Nov 22;2(12). doi: 10.1126/scirobotics.aaq1155.
2
Oral Insulin Delivery Platforms: Strategies To Address the Biological Barriers.口服胰岛素递药平台:克服生物学屏障的策略。
Angew Chem Int Ed Engl. 2020 Nov 2;59(45):19787-19795. doi: 10.1002/anie.202008879. Epub 2020 Sep 25.
3
Engineered algae: A novel oxygen-generating system for effective treatment of hypoxic cancer.工程藻类:一种新型供氧系统,可有效治疗缺氧性癌症。
Nat Commun. 2025 Aug 15;16(1):7614. doi: 10.1038/s41467-025-62360-2.
4
Unlocking the potential of microalgae-derived therapeutic carriers: Characteristics, types, and nanomedical applications.释放微藻衍生治疗载体的潜力:特性、类型及纳米医学应用
Mater Today Bio. 2025 Jul 3;33:102037. doi: 10.1016/j.mtbio.2025.102037. eCollection 2025 Aug.
5
Enteric Delivery of Probiotics: Challenges, Techniques, and Activity Assays.益生菌的肠道递送:挑战、技术及活性测定
Foods. 2025 Jun 30;14(13):2318. doi: 10.3390/foods14132318.
6
Microalgae-driven microrobots: revolutionizing drug delivery and targeted therapy in biopharmaceuticals.微藻驱动的微型机器人:革新生物制药中的药物递送和靶向治疗
Adv Biotechnol (Singap). 2025 Jul 1;3(3):19. doi: 10.1007/s44307-025-00073-9.
7
Oxidative Stress, Gut Bacteria, and Microalgae: A Holistic Approach to Manage Inflammatory Bowel Diseases.氧化应激、肠道细菌与微藻:一种管理炎症性肠病的整体方法。
Antioxidants (Basel). 2025 Jun 9;14(6):697. doi: 10.3390/antiox14060697.
8
Microalgal-enhanced cerium oxide nanotherapeutics for alleviating inflammatory bowel disease via scavenging reactive oxygen species and modulating gut microbiota in colitis.微藻增强的氧化铈纳米疗法通过清除活性氧和调节结肠炎中的肠道微生物群来缓解炎症性肠病。
Mater Today Bio. 2025 Jun 6;33:101945. doi: 10.1016/j.mtbio.2025.101945. eCollection 2025 Aug.
9
Living photosynthetic micro/nano-platforms: Engineering unicellular algae for biomedical applications.活体光合微纳平台:用于生物医学应用的工程化单细胞藻类
Bioact Mater. 2025 May 27;51:575-597. doi: 10.1016/j.bioactmat.2025.05.023. eCollection 2025 Sep.
10
Microalgae-carrying nanomedicine for bioadhesive drug delivery for treating chemotherapy-induced intestinal injury.携带微藻的纳米药物用于生物粘附性药物递送以治疗化疗引起的肠道损伤。
Asian J Pharm Sci. 2025 Apr;20(2):101024. doi: 10.1016/j.ajps.2025.101024. Epub 2025 Feb 8.
Sci Adv. 2020 May 20;6(21):eaba5996. doi: 10.1126/sciadv.aba5996. eCollection 2020 May.
4
Biodegradable Microalgae-Based Carriers for Targeted Delivery and Imaging-Guided Therapy toward Lung Metastasis of Breast Cancer.基于可生物降解微藻的载体用于靶向递药和成像引导治疗乳腺癌肺转移
Small. 2020 May;16(20):e2000819. doi: 10.1002/smll.202000819. Epub 2020 Apr 15.
5
Microalgae aqueous extracts exert intestinal protective effects in Caco-2 cells and dextran sodium sulphate-induced mouse colitis.微藻水提物对 Caco-2 细胞和葡聚糖硫酸钠诱导的小鼠结肠炎发挥肠道保护作用。
Food Funct. 2020 Jan 29;11(1):1098-1109. doi: 10.1039/c9fo01028a.
6
Protective Effect of Extract against Dextran-Sulfate-Sodium-Induced Ulcerative Colitis in Rats. 提取物对葡聚糖硫酸钠诱导的大鼠溃疡性结肠炎的保护作用。
Nutrients. 2019 Sep 29;11(10):2309. doi: 10.3390/nu11102309.
7
Oral Delivery of Biologics for Precision Medicine.精准医学的生物制剂口服递药
Adv Mater. 2020 Apr;32(13):e1901935. doi: 10.1002/adma.201901935. Epub 2019 Jun 20.
8
Challenges and Recent Progress in Oral Drug Delivery Systems for Biopharmaceuticals.生物制药口服给药系统的挑战与最新进展
Pharmaceutics. 2019 Mar 19;11(3):129. doi: 10.3390/pharmaceutics11030129.
9
Adapting liposomes for oral drug delivery.使脂质体适用于口服药物递送。
Acta Pharm Sin B. 2019 Jan;9(1):36-48. doi: 10.1016/j.apsb.2018.06.005. Epub 2018 Jun 20.
10
The therapeutic potential of curcumin: A review of clinical trials.姜黄素的治疗潜力:临床试验综述。
Eur J Med Chem. 2019 Feb 1;163:527-545. doi: 10.1016/j.ejmech.2018.12.016. Epub 2018 Dec 7.